Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer

BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS: We analyzed 33 patients who had...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lee, Ji Hyun, Kim, Sung-Hyun, Oh, Sung Yong, Lee, Suee, Lee, Hojin, Lee, Hye Jung, Kim, Hyo-Jin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Association of Internal Medicine 2013
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654129/
https://ncbi.nlm.nih.gov/pubmed/23682225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2013.28.3.314
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg